The Beaufort Memorial Keyserling Cancer Center (KCC) strives to provide its patients with the latest, most effective cancer treatment available.
One component of cancer care that benefits current and future patients is the tracking of treatment effectiveness. Since 2007, KCC has collected patient information designed to advance treatment as well as prevention.
KCC drew on the information for two studies whose data dates from 2011 and 2007, respectively. The results of both studies were published in 2013.
One study, devoted to breast cancer, looked at age at diagnosis, stage of disease, prevalence and mortality over five years in African Americans compared with those in Caucasians. To view 2013 breast cancer study results click here.
The other study reviewed adherence to National Cancer Center Network Guidelines and five-year survival rates for patients with stage III colon cancer treated at KCC. The KCC data was compared with that for patients with stage III disease in the National Cancer Data Base as a whole. To view 2013 colon cancer study results click here.
Both studies offer encouragement for patients receiving treatment for breast or colon cancer at KCC.
For a complete list by site of cancers diagnosed at Beaufort Memorial Hospital in 2013, click here.
Advanced Surgical Treatment for Prostate Cancer
Advanced surgical treatment for prostate cancer also was introduced at Keyserling Cancer Center in 2013. For more information about the treatment, click here.
Keyserling Cancer Center is affiliated with Duke Medicine. Its Community Cancer Program is accredited by the American College of Surgeons Commission on Cancer. Accreditation of a cancer center is granted only to those facilities that have voluntarily committed to provide the best in cancer diagnosis and treatment and are able to comply with established Commission on Cancer standards.